Axogen, Inc. Proceeds from Long-Term Debt Issued
Axogen, Inc. (AXGN) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-03-05
- Axogen, Inc. proceeds from issuance of long-term debt for the quarter ending 2022-12-31 was $0.00.
- Axogen, Inc. proceeds from issuance of long-term debt for the quarter ending 2022-09-30 was $0.00.
- Axogen, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-12-31 was $0.00.
- Axogen, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-09-30 was $0.00.
- Axogen, Inc. proceeds from issuance of long-term debt for fiscal 2023 was $0.00.
- Axogen, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Axogen, Inc. proceeds from issuance of long-term debt for fiscal 2021 was $15.00M, a 57.14% decline from fiscal 2020.
- Axogen, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $35.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 10-K · filed 2024-03-05 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $15.00M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $15.00M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $15.00M 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $35.00M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $35.00M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $35.00M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2012-09-30 | $1.75M 10-Q · filed 2013-10-30 | |||
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $7.50M derived: sum of 2 quarters · filed 2013-08-07 | $10.50M 10-K/A · filed 2013-08-07 | |
| 2011-09-30 | $7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $10.50M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $3.00M 10-Q · filed 2012-08-14 | |||
| 2010-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $3.70M 10-K · filed 2012-03-15 | ||
| 2010-09-30 | $1.32M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |